Novel SIRT5 Enzymatic Activity Regulates Cellular Mechanisms of Aging and Disease
新型 SIRT5 酶活性调节衰老和疾病的细胞机制
基本信息
- 批准号:8650231
- 负责人:
- 金额:$ 35.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-02-01 至 2019-01-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAcetylationAcylationAddressAdvanced DevelopmentAgeAgingAging-Related ProcessAmino AcidsAutophagocytosisBackBiological AssayCaloric RestrictionCell LineCell RespirationCellsCellular AssayChargeChemicalsChronicChronic DiseaseCoenzyme ADataDeacetylaseDevelopmentDiabetes MellitusDiseaseEconomic BurdenEnsureExhibitsExperimental DesignsFastingFoundationsFunctional disorderGlutaryl-CoA dehydrogenaseGoalsHealthHepaticHomeostasisHumanIn VitroKnowledgeLeadLipidsLysineMalignant NeoplasmsMammalian CellMapsMeasuresMissionMitochondriaMitochondrial ProteinsModelingModificationMolecularMusNatureNutrientPathway interactionsPhysiologicalPlayPopulationPositioning AttributePost-Translational Protein ProcessingProtein AcetylationProteinsProteomicsPublic HealthRegulationResearchResearch PersonnelResearch ProposalsResolutionRiskRisk FactorsRoleSamplingSideSignal PathwaySirtuinsSiteStagingTestingUnited States National Institutes of HealthWorkage relatedagedbasedeprivationenzyme activityfeedinghealthy aginghuman diseasein vivoinnovationknock-downmiddle agemitochondrial dysfunctionmouse modelnoveloxidationpreventprogramsprotein functionpublic health relevancesocial
项目摘要
Current research on aging has largely focused the molecular mechanisms of age-related
diseases, and mitochondrial dysfunction has been associated with several human diseases of
aging. However, the cellular mechanisms of mitochondrial dysfunction and how they lead to
age-related diseases are not known. Chemical modifications to mitochondrial proteins control
several aspects of mitochondrial function, and the long-term goal of this project is to understand
how these modifications are regulated by the NAD(+)-dependent sirtuin deacylases and
influence the diseases of aging. The objective of this proposal is to define the role of SIRT5 in
the molecular mechanisms of aging. The central hypothesis is that SIRT5 regulates
mitochondrial function by removing a newly discovered acyl modification from mitochondrial
proteins. In the absence of SIRT5, mitochondrial proteins will become hyper-acylated, have
reduced mitochondrial function, and exhibit several markers of accelerated aging. The rationale
for this hypothesis is based on preliminary data, which suggests an important role for SIRT5 in
the cellular mechanisms of aging and disease. To test these hypotheses, three specific aims will
be pursued: 1. Determine the changes in protein acylation as a function of age, using a
proteomic strategy to quantify hepatic mitochondrial protein acylation from young, middle-aged,
and old mice; 2. Determine the effect of this novel acyl modification on protein function by using
a combination of cell and murine models, in order to to measure the changes in protein activity
of specific proteins, as well as the overall function of mitochondria; 3. Determine role of SIRT5
on aging by measuring several physiological parameters of aging using both in vitro cellular
assays and in vivo assays in mice, to determine how SIRT5 maintains mitochondrial and cellular
homeostasis during aging. This study combines a novel protein modification, a comprehensive
experimental design, and an innovative conceptual framework. Furthermore, this study will build
a foundation for this early-stage investigator and ensure a successful research program focused
on the cellular mechanisms of aging and disease. Importantly, the proposed research is
significant because it is expected to advance and expand understanding how mitochondrial
dysfunction can lead to age-related diseases. Ultimately such knowledge has the potential to
inform the development of new therapies against several diseases of aging.
目前对衰老的研究主要集中在衰老的分子机制上。
疾病,线粒体功能障碍与几种人类疾病有关
衰老。然而,线粒体功能障碍的细胞机制及其如何导致
与年龄相关的疾病尚不清楚。线粒体蛋白控制的化学修饰
线粒体功能的几个方面,这个项目的长期目标是了解
这些修饰是如何被依赖于NAD(+)的sirtuin脱酰酶和
影响衰老的疾病。这项提案的目标是定义SIRT5在
衰老的分子机制。中心假说是SIRT5调节
线粒体去掉一个新发现的酰基修饰后的功能
蛋白质。在没有SIRT5的情况下,线粒体蛋白质将变得超酰化,
线粒体功能降低,并表现出几个加速衰老的标志。其基本原理是
因为这一假设是基于初步数据,这表明SIRT5在
衰老和疾病的细胞机制。为了检验这些假说,有三个具体目标
继续研究:1.确定蛋白质酰化的变化作为年龄的函数,使用
用蛋白质组学方法定量检测青年、中年和老年人群肝脏线粒体蛋白质酰化
和老年小鼠;2.通过测定这种新的酰基修饰对蛋白质功能的影响
结合细胞和小鼠模型,以测量蛋白质活性的变化
3.确定SIRT5的作用
用两种体外细胞测量衰老的几个生理参数研究衰老
在小鼠体内的检测,以确定SIRT5如何维持线粒体和细胞
衰老过程中的动态平衡。这项研究结合了一种新的蛋白质修饰,一种全面的
实验设计,以及创新的概念框架。此外,这项研究将建立
为早期研究人员奠定基础,并确保成功的研究计划专注于
关于衰老和疾病的细胞机制。重要的是,拟议的研究是
意义重大,因为它有望推进和扩大对线粒体如何
功能障碍会导致与年龄相关的疾病。最终,这样的知识有可能
告知针对几种衰老疾病的新疗法的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew D Hirschey其他文献
Matthew D Hirschey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew D Hirschey', 18)}}的其他基金
Studies on the impact of acetyl-cysteine on metabolism
乙酰半胱氨酸对代谢影响的研究
- 批准号:
10574934 - 财政年份:2022
- 资助金额:
$ 35.73万 - 项目类别:
Determining the Sub-Cellular Organelles that Link Lipid Signaling and Epigenetics
确定连接脂质信号传导和表观遗传学的亚细胞器
- 批准号:
9763211 - 财政年份:2019
- 资助金额:
$ 35.73万 - 项目类别:
Post-Translational and Epigenetic Control of Branched-Chain Amino Acid Metabolism
支链氨基酸代谢的翻译后和表观遗传控制
- 批准号:
10225807 - 财政年份:2018
- 资助金额:
$ 35.73万 - 项目类别:
Post-Translational and Epigenetic Control of Branched-Chain Amino Acid Metabolism
支链氨基酸代谢的翻译后和表观遗传控制
- 批准号:
9930167 - 财政年份:2018
- 资助金额:
$ 35.73万 - 项目类别:
Post-Translational and Epigenetic Control of Branched-Chain Amino Acid Metabolism
支链氨基酸代谢的翻译后和表观遗传控制
- 批准号:
10164761 - 财政年份:2018
- 资助金额:
$ 35.73万 - 项目类别:
Studies on the Mechanisms by which SIRT5 Regulates Aging and Disease
SIRT5调节衰老和疾病的机制研究
- 批准号:
10442722 - 财政年份:2014
- 资助金额:
$ 35.73万 - 项目类别:
Novel SIRT5 Enzymatic Activity Regulates Cellular Mechanisms of Aging and Disease
新型 SIRT5 酶活性调节衰老和疾病的细胞机制
- 批准号:
9210031 - 财政年份:2014
- 资助金额:
$ 35.73万 - 项目类别:
Novel SIRT5 Enzymatic Activity Regulates Cellular Mechanisms of Aging and Disease
新型 SIRT5 酶活性调节衰老和疾病的细胞机制
- 批准号:
8795651 - 财政年份:2014
- 资助金额:
$ 35.73万 - 项目类别:
Studies on the Mechanisms by which SIRT5 Regulates Aging and Disease
SIRT5调节衰老和疾病的机制研究
- 批准号:
10183107 - 财政年份:2014
- 资助金额:
$ 35.73万 - 项目类别:
Studies on the Mechanisms by which SIRT5 Regulates Aging and Disease
SIRT5调节衰老和疾病的机制研究
- 批准号:
10661571 - 财政年份:2014
- 资助金额:
$ 35.73万 - 项目类别:
相似海外基金
Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
- 批准号:
EP/Y000331/1 - 财政年份:2023
- 资助金额:
$ 35.73万 - 项目类别:
Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
- 批准号:
10677295 - 财政年份:2023
- 资助金额:
$ 35.73万 - 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
- 批准号:
10635599 - 财政年份:2023
- 资助金额:
$ 35.73万 - 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
- 批准号:
10752320 - 财政年份:2023
- 资助金额:
$ 35.73万 - 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
- 批准号:
478927 - 财政年份:2023
- 资助金额:
$ 35.73万 - 项目类别:
Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
- 批准号:
10855703 - 财政年份:2023
- 资助金额:
$ 35.73万 - 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
- 批准号:
10654210 - 财政年份:2023
- 资助金额:
$ 35.73万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 35.73万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 35.73万 - 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
- 批准号:
10726986 - 财政年份:2023
- 资助金额:
$ 35.73万 - 项目类别:














{{item.name}}会员




